Digraph

Plazomicin

PlazomicinZemdriPlazomycin

Parent topics

This topic

Recent activity

You must be signed in to add and move topics and links.

2020-03 Discovery of a novel integron-borne aminoglycoside resistance gene present in clinical pathogens by screening environmental bacterial communities
Plazomicin Studies of antibiotic resistance genes
Achaogen-Canary in the Coal Mine or Developer of an Unwanted Product?
https://www.contagionlive.com/publications/contagion/2019/june/achaogen-canary-in-the-coal-mine-or-developer-of-an-unwanted-product
2019-04 Achaogen files for bankruptcy Carbapenem-resistant Enterobacteriaceae (CRE)Plazomicin
Aligning Payment And Prevention To Drive Antibiotic Innovation For Medicare Beneficiaries
https://www.healthaffairs.org/do/10.1377/hblog20190802.505113/full/
2019-04 Achaogen files for bankruptcy 2019-08 Centers for Medicaid & Medicare Services announcement about changes to antibiotic reimbursements Plazomicin
Antibiotic developer Melinta files for bankruptcy | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/12/antibiotic-developer-melinta-files-bankruptcy
2019-04 Achaogen files for bankruptcy 2019-12 Melinta files for bankruptcy Antibiotic resistance and pharmaceutical business models DISARM Act model legislation Delafloxacin Plazomicin
Cipla USA Furthers AMR Stewardship With Acquisition of Key Anti-infective ZEMDRI™ (IV Plazomicin)
https://www.prnewswire.com/news-releases/cipla-usa-furthers-amr-stewardship-with-acquisition-of-key-anti-infective-zemdri-iv-plazomicin-300890471.html
Plazomicin
Crisis Looms in Antibiotics as Drug Makers Go Bankrupt - The New York Times
https://www.nytimes.com/2019/12/25/health/antibiotics-new-resistance.html
2019-02 Aradigm files for bankruptcy 2019-04 Achaogen files for bankruptcy Antibiotic resistance and pharmaceutical business models Articles in the New York Times Biomedical Advanced Research and Development Authority (BARDA)CARB-X DISARM Act model legislation Eravacycline Plazomicin
Papers highlight challenges, solutions in developing antibiotics | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/10/papers-highlight-challenges-solutions-developing-antibiotics
2019-04 Achaogen files for bankruptcy Antibiotic resistance and pharmaceutical business models Carbapenem-resistant Enterobacteriaceae (CRE)Ceftazidime-avibactam Meropenem-vaborbactam Plazomicin
WHO adds new antibiotics to essential medicines list | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/07/who-adds-new-antibiotics-essential-medicines-list
Ceftazidime-avibactam Meropenem-vaborbactam Plazomicin
What's New From the CLSI Subcommittee on Antimicrobial Susceptibility Testing
https://www.contagionlive.com/publications/contagion/2019/october/whats-new-from-the-clsi-subcommittee-on-antimicrobial-susceptibility-testing
Azithromycin CLSI Subcommittee on Antimicrobial Susceptibility Testing (AST)Cefiderocol Ceftazidime-avibactam Ceftriaxone Colistin Daptomycin Enterococcus faecalis Enterococcus faecium Meropenem-vaborbactam Plazomicin Polymyxin B Polymyxins
World AMR Congress: Fighting Anti-Microbial Resistance | BioSpace
https://www.biospace.com/article/world-amr-congress-fighting-anti-microbial-resistance/
2019-04 Achaogen files for bankruptcy Antibiotic resistance and pharmaceutical business models Plazomicin Working to Fight AMR